We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

77 hedge funds and large institutions have $113M invested in Kindred Biosciences, Inc. in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 24

5% less capital invested

Capital invested by funds: $118M → $113M (-$5.61M)

7% less funds holding

Funds holding: 83 → 77 (-6)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

Holders
77
Holders Change
-6
Holders Change %
-7.23%
% of All Funds
1.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
27
Reduced
24
Closed
13
Calls
$325K
Puts
–
Net Calls
+$325K
Net Calls Change
-$208K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.11M
2
Renaissance Technologies
Renaissance Technologies
New York
+$699K
3
AI
Ariel Investments
Illinois
+$634K
4
Wells Fargo
Wells Fargo
California
+$385K
5
Morgan Stanley
Morgan Stanley
New York
+$345K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.15M
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$404K
3
HP
Hound Partners
New York
-$359K
4
Squarepoint
Squarepoint
New York
-$328K
5
Allianz Asset Management
Allianz Asset Management
Germany
-$235K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
76
Millennium Management
New York
$294 -$3.15M -753,189 -92%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
77
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$404K -90,000 Closed
HP
78
Hound Partners
New York
– -$359K -80,000 Closed
Squarepoint
79
Squarepoint
New York
– -$328K -72,941 Closed
Two Sigma Investments
80
Two Sigma Investments
New York
– -$101K -22,415 Closed
SG Americas Securities
81
SG Americas Securities
New York
– -$90K -20,110 Closed
BFM
82
Boothbay Fund Management
New York
– -$75K -16,610 Closed
State of Wisconsin Investment Board
83
State of Wisconsin Investment Board
Wisconsin
– -$74K -16,400 Closed
ACI
84
AMP Capital Investors
Australia
– -$60K -14,200 Closed
PA
85
Parallel Advisors
California
– -$13K -3,000 Closed
BCV
86
Banque Cantonale Vaudoise
Switzerland
– -$10K -2,205 Closed
CG
87
Cutler Group
California
– -$5K -1,200 Closed
PAG
88
Private Advisor Group
New Jersey
– -$4K -1,000 Closed
CAN
89
Cetera Advisor Networks
California
– -$1K -200 Closed
TWA
90
TCI Wealth Advisors
Arizona
– +$414 +99 New
1 2 3
4

KIN Hedge Fund Activity: Q3 2020 in Review

77 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q3 2020, worth a combined $113M — down 4.7% from $118M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of KIN and 8 opened new positions — a net loss of 5 holders — while 24 trimmed existing stakes and 27 added.

The largest buyer was Acadian Asset Management, adding an estimated $1.11M. The largest seller was Millennium Management, cutting an estimated $3.15M.

  • 77 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q3 2020, down from 83 in Q2 2020.
  • Funds reported $113M of Kindred Biosciences, Inc. stock for Q3 2020, down 4.7% quarter-over-quarter.
  • 8 funds opened new Kindred Biosciences, Inc. positions in Q3 2020 and 13 closed out, a net change of -5 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q3 2020 was Acadian Asset Management, an estimated $1.11M added.
  • The largest Kindred Biosciences, Inc. seller in Q3 2020 was Millennium Management, an estimated $3.15M sold.

Based on aggregated 13F filings for Q3 2020.